⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACRS News
Aclaris Therapeutics, Inc.
Aclaris Therapeutics Added to the NASDAQ Biotechnology Index (NBI)
globenewswire.com
ACRS
Thor Equities Secures $18.25M Financing for Wynwood Sites
globenewswire.com
ACRS
Data Backup and Recovery Software Market to Reach New Heights as Cyberattacks Surge and Cloud Adoption Accelerates | Valuates Reports
prnewswire.com
VEE
VRT
CVLT
ACRS
KAYS
NTAP
CF
Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
globenewswire.com
ACRS
Aclaris Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
ACRS
Aclaris Therapeutics to Participate in Three November Healthcare Conferences
globenewswire.com
ACRS
Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025
globenewswire.com
ACRS
JAK Inhibitors Market to Register Notable Growth During the Forecast Period (2026-2036) Through Expanding Clinical and Commercial Landscape | DelveInsight
prnewswire.com
INCY
PRTH
BHC
ACRS
PFE
AMGN
BMY
VERU
LLY
MRK
ABBV